Science Explorer Back to mapMap
Discussion
Researcher · Toscana Life Sciences · Italy

Diego Piccioli

Diego Piccioli publishes mostly in Immunology, Endocrinology and Infectious Diseases, on topics such as Immunotherapy and Immune Responses, Immune Response and Inflammation and Immune Cell Function and Interaction.

ORCID 0000-0002-5809-4455 OpenAlex
World rank
#2,668,166
of 7,710,434 ranked researchers
Rank in Italy
#89,819
of 242,206
Works
27
Citations
1.6k
Citations per work
60.2
h-index
16
i10-index 18Top 44% in Immunology
Diego Piccioli

What does Diego Piccioli research?

Diego Piccioli's work is mostly in Immunology and Microbiology (62%), Medicine (14%), Biochemistry, Genetics and Molecular Biology (12%).

Life Sciences: 20 works · 73.6% of their workImmunology and Microbiology: 17 works · 61.8% of their workImmunology: 15 works · 53.9% of their workMicrobiology: 2 works · 7.9% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.8% of their workEndocrinology: 2 works · 7.9% of their workMolecular Biology: 1 works · 3.9% of their workHealth Sciences: 4 works · 14.5% of their workMedicine: 4 works · 14.5% of their workInfectious Diseases: 2 works · 7.9% of their workEpidemiology: 2 works · 6.6% of their workEverything else: 3 works · 11.9% of their workTHEIR WORKDiego Piccioli27works
Life Sciences74%Health Sciences14%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology1761.8%
    2. Biochemistry, Genetics and Molecular Biology311.8%
    1. Medicine414.5%
  3. Everything else311.9%
  1. 1Immunology54% of their works
  2. 2Endocrinology8% of their works
  3. 3Infectious Diseases8% of their works
  4. 4Microbiology8% of their works
  5. 5Epidemiology7% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Diego Piccioli's research?

The keywords of their largest research topics: Immunity, Cancer Immunotherapy, Dendritic Cells, Pattern Recognition Receptors, Toll-like Receptors, Epidemiology, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Immunity192 topics
  2. Cancer Immunotherapy141 topic
  3. Dendritic Cells141 topic
  4. Pattern Recognition Receptors101 topic
  5. Toll-like Receptors101 topic
  6. Epidemiology82 topics
  7. NK Cell Recognition81 topic
  8. Natural Killer Cells81 topic
  9. Foxp361 topic
  10. TGF-ß61 topic
  11. Bacterial Meningitis51 topic
  12. Escherichia coli51 topic
  13. Neisseria meningitidis51 topic
  14. Pathogenicity51 topic
  15. Antibiotic-Associated Diarrhea31 topic
  16. Fecal Microbiota Transplantation31 topic
  17. RNA Interference21 topic
  18. siRNA Delivery21 topic

Where does Diego Piccioli work?

Diego Piccioli's main affiliation in the publication record is Toscana Life Sciences, Italy.

How many publications and citations does Diego Piccioli have?

OpenAlex counts 27 works and 1,625 citations for Diego Piccioli, an h-index of 16, ranking #2,668,166 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Diego Piccioli. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.